Commitments and Contingencies (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Manufacturing commitments | ||||
| Non-cancelable purchase commitments | $ 215,633 | $ 215,633 | ||
| Amount of purchase commitment obligation due within one year | 77,628 | 77,628 | ||
| Research and development | 32,786 | $ 24,166 | 101,160 | $ 62,244 |
| Loss contingency | ||||
| Loss contingency accrual | 0 | |||
| Abiprubart | ||||
| Manufacturing commitments | ||||
| Research and development | $ 0 | 0 | $ 2,500 | |
| PSOs | ||||
| Long-term incentive plan | ||||
| Performance cash award expense | 0 | |||
| 2018 Plan | ||||
| Long-term incentive plan | ||||
| Estimated amount of cash award in the event performance goals are achieved | $ 24,585 | $ 24,585 | ||
| X | ||||||||||
- Definition The estimated amount of cash award in the event performance goals are achieved. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of purchase commitment obligation maturing in the next rolling twelve months following the latest balance sheet. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of loss (reversal of loss) recognized for loss contingency liability. Includes, but is not limited to, effect of revision in previously reported estimate. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|